OTCMKTS:MSLP MusclePharm - MSLP Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding MusclePharm Co. Please log in to your account or sign up in order to add this asset to your watchlist. $0.0013 0.00 (0.00%) (As of 01/30/2023 12:00 AM ET) Add Compare Share Share Today's Range$0.0013▼$0.001350-Day Range N/A52-Week Range$0.0002▼$0.0002VolumeN/AAverage Volume26,442 shsMarket Capitalization$43,407.00P/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsFinancialsInsider TradesHeadlinesSEC FilingsShort Interest About MusclePharm (OTCMKTS:MSLP) StockMusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.Read More Receive MSLP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MusclePharm and its competitors with MarketBeat's FREE daily newsletter. Email Address MSLP Stock News HeadlinesDecember 23, 2022 | thestreet.comWhy MusclePharm (MSLP) Stock Is Up TodayJuly 6, 2022 | finance.yahoo.comMusclePharm Announces the Launch of FitMiss EnergyJanuary 31, 2023 | Porter & Company (Ad)The Next Big Crisis Is HereYou just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.June 23, 2022 | seekingalpha.comMusclePharm Files For Uplisting IPO To NasdaqJune 7, 2022 | seekingalpha.comMusclePharm announces additional private placement of $2.5M senior secured notesMay 24, 2022 | finance.yahoo.comMusclePharm to Present at the LD Micro Invitational XII ConferenceMay 16, 2022 | benzinga.comMusclePharm Announces First Quarter 2022...May 16, 2022 | seekingalpha.comMusclePharm Corporation (MSLP) CEO Ryan Drexler on Q1 2022 Results - Earnings Call TranscriptJanuary 31, 2023 | UNKNOWN (Ad)Hot craft spirits opportunity you don't want to missAward winning products. Global distribution. New distillery. New products.May 16, 2022 | finance.yahoo.comMusclePharm Announces First Quarter 2022 Financial ResultsMay 5, 2022 | morningstar.comCorrection: MusclePharm Announces Fourth Quarter and Fiscal Year 2021 Financial ResultsApril 14, 2022 | finance.yahoo.comMusclePharm Announces Fourth Quarter and Fiscal Year 2021 Financial ResultsApril 12, 2022 | finance.yahoo.comMusclePharm to Announce Fourth Quarter and Full Year 2021 Financial Results on Thursday, April 14, 2022March 31, 2022 | finance.yahoo.comMusclePharm Announces Launch into Ready-to-Drink Protein CategoryMarch 11, 2022 | seekingalpha.comMusclePharm releases preliminary Q421 resultsMarch 11, 2022 | finance.yahoo.comMusclePharm Announces Preliminary Fourth Quarter and Full Year 2021 Revenue and Begins Fiscal 2022 with Strong First Quarter GuidanceMarch 2, 2022 | finance.yahoo.comMusclePharm to Participate at the 34th Annual Roth ConferenceFebruary 24, 2022 | finance.yahoo.comMusclePharm Announces Partnership with Costco for MP Energy Drink in Southern California and Hawaii RegionsFebruary 15, 2022 | seekingalpha.comMusclePharm teams up with Alliance Sales & MarketingFebruary 15, 2022 | finance.yahoo.comMusclePharm Announces National Partnership with Alliance Sales & Marketing for Energy Drink BusinessFebruary 7, 2022 | finance.yahoo.comMusclePharm Rolls Out New and Improved MP Combat Protein Powder to Costco USFebruary 2, 2022 | seekingalpha.comMusclePharm expands distribution channel with Amazon tie-up for energy drink lineFebruary 2, 2022 | finance.yahoo.comMusclePharm Dramatically Expands Distribution Channel with Amazon.com; Offering Three Flavors of MP Combat Energy Drinks to Its 200 Million Prime MembersNovember 15, 2021 | finance.yahoo.comMusclePharm Announces Third Quarter 2021 Financial ResultsOctober 29, 2021 | finance.yahoo.comMusclePharm adds former Rockstar Energy executive to MP beverage team to lead product development and marketing for two new Performance Energy drinksOctober 27, 2021 | finance.yahoo.comMusclePharm Reports 2014 Fourth-Quarter and Full-Year Financial ResultsOctober 15, 2021 | au.finance.yahoo.comGlobal Warming Solutions, Inc. Announces the Appointment of a New Board MemberSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive MSLP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MusclePharm and its competitors with MarketBeat's FREE daily newsletter. Email Address MSLP Company Calendar Last Earnings8/10/2015Today1/30/2023Next Earnings (Estimated)3/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorConsumer Staples Current SymbolOTCMKTS:MSLP CUSIPN/A CIK1415684 Webwww.musclepharm.com Phone(800) 292-3909FaxN/AEmployees27Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.58) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-12,870,000.00 Net Margins-38.51% Pretax Margin-38.52% Return on EquityN/A Return on Assets-169.56% Debt Debt-to-Equity RatioN/A Current Ratio0.25 Quick Ratio0.23 Sales & Book Value Annual Sales$50.04 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.94) per share Price / Book0.00Miscellaneous Outstanding Shares33,390,000Free Float13,121,000Market Cap$43,407.00 OptionableNot Optionable Beta-0.07 Key ExecutivesMr. Ryan Charles Drexler (Age 51)Exec. Chairman & CEO Comp: $1.64MJohn Mills MillsSr. Managing DirectorMr. Gary Charles Shirshac (Age 60)Interim Chief Financial Officer Mr. Eric Chin (Age 42)Chief Accounting Officer & Director Dr. Roscoe M. Moore Jr. (Age 77)DSc, DVM, MPH, Ph.D., Chief Scientific Director & Member of Scientific Advisory Board Mr. Mark E. Groussman (Age 49)Consultant More ExecutivesKey CompetitorsChina Marine Food GroupOTCMKTS:CMFONew World BrandsOTCMKTS:NWBDSino Agro FoodOTCMKTS:SIAFNewAgeNASDAQ:NBEVQBrewBilt BrewingOTCMKTS:SIMLDView All Competitors MSLP Stock - Frequently Asked Questions How have MSLP shares performed in 2023? MusclePharm's stock was trading at $0.0007 at the beginning of the year. Since then, MSLP stock has increased by 85.7% and is now trading at $0.0013. View the best growth stocks for 2023 here. When is MusclePharm's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, March 9th 2023. View our MSLP earnings forecast. How were MusclePharm's earnings last quarter? MusclePharm Co. (OTCMKTS:MSLP) released its quarterly earnings results on Monday, August, 10th. The company reported ($0.51) earnings per share for the quarter, missing analysts' consensus estimates of ($0.19) by $0.32. The company had revenue of $50.48 million for the quarter, compared to analysts' expectations of $55 million. What other stocks do shareholders of MusclePharm own? Based on aggregate information from My MarketBeat watchlists, some companies that other MusclePharm investors own include Dalradian Resources (DALR), EVRAZ (EVRZF), Rent-A-Center (RCII), Avino Silver & Gold Mines (ASM), AdvanSix (ASIX), Accuray (ARAY), Apollo Global Management (APO), TD Ameritrade (AMTD), Alaska Communications Systems Group (ALSK) and Alnylam Pharmaceuticals (ALNY). What is MusclePharm's stock symbol? MusclePharm trades on the OTCMKTS under the ticker symbol "MSLP." How do I buy shares of MusclePharm? Shares of MSLP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is MusclePharm's stock price today? One share of MSLP stock can currently be purchased for approximately $0.00. How much money does MusclePharm make? MusclePharm (OTCMKTS:MSLP) has a market capitalization of $43,407.00 and generates $50.04 million in revenue each year. The company earns $-12,870,000.00 in net income (profit) each year or ($0.58) on an earnings per share basis. How can I contact MusclePharm? MusclePharm's mailing address is 4400 VANOWEN STREET, BURBANK CA, 80239. The official website for the company is www.musclepharm.com. The company can be reached via phone at (800) 292-3909 or via email at investors@musclepharm.com. This page (OTCMKTS:MSLP) was last updated on 1/31/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.